Braga

Portugal

202 total trials 90 recruiting

Filter these 202 trials by phase, condition, sponsor and more.

Open in Search →

A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with S … Ended

2023-505786-88-00 5 2021-04-25 Severe and inadequately controlled asthma
Study to assess the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab in chronic obstructive pulmonary disease (COPD) (AER … Ended

2024-512012-21-00 5 2021-04-08 Chronic Obstructive Pulmonary Disease
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended

2023-504990-19-00 5 2021-04-06 Agitation in Patients With Dementia of the Alzheimer's Type
Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to Assess Efficacy and Safety of D-P … Ended

2023-509698-21-00 5 2021-03-17 Prevention of post abdominal surgery incisional infection.
A study to evaluate the effects of ALIS based treatment in patients newly diagnosed with nontuberculous mycobacterial lung infection caused … Ended

2023-505273-33-00 5 2021-02-15 "Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor tolebrutinib (SAR442168) (PERSEUS) Ended

2024-514495-41-00 5 2020-11-04 Primary Progressive Multiple Sclerosis
An open-label study evaluating ofatumumab treatment effectiveness and PROs in subjects with RMS transitioning from fumarate-based RMS approv … Ended

2023-507493-41-00 5 2020-08-04 relapsing multiple sclerosis (RMS)
Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema) – Measure Up 2 Ended

2022-502936-38-00 5 2019-01-09 Moderate and Severe Atopic Dermatitis
A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Multiple Sclerosis Previously Enrolled in A F. Hoffmann-la … Ended

2023-506543-41-00 5 2018-07-25 Multiple sclerosis (MS)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-916 in … Ended

2022-500691-59-00 4 Alzheimer's disease (AD)

Showing 193–202 of 202 trials